EXCEDE
(Ceftiofur Crystalline Free Acid)
Sterile Suspension
Equivalent to 200 mg/ml caftofur
Approved by FDA under NADA / 141-209
For subcutaneous injection in the posterior aspect of the ear where it attaches to the head (base of the ear) in lactating dairy cattle. For subcutaneous injection in the middle third of the posterior aspect of the ear or in the posterior aspect of the ear where it attaches to the head (base of the ear) in beef and non-lactating dairy cattle. Not for use in calves to be processed for veal.
For intramuscular injection in the horse.
For use in animals only
Caution:
Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian.
Federal Law prohibits extra-label use of this drug in cattle for disease prevention purposes; at unapproved doses; frequencies, durations, or routes of administration; and in unapproved major food producing species/ production dasses.
See package insert for complete product infermation.
Cattle: EXCEDE Sterile Sospension is Indicated
for the treatmeet of bovine respiratory disease (BRD) and for the treatment ef bovine feet rot (Interdigital necrebacillesis) in beef and non-lactating dairy, and lactating dairy cattle.
For the contrel of respiratary doease is beef and non-lactating dairy caftle which are at high risk of developing BRD
For the treatment of acute matritis (0-10 days post-partom) associated with bacterial organisms susceptible to ceftisfur in lactating dairy cattle.
Horses: EXCEDE Sterile Saspensien is indicated for the treatment of lower respiratory tract infections in horses caused by susceptible strains of Streptococras equrssposepidemicus
TREATMENT:
Cattle (BRD and Bevine Foot Rat): Administer as a single subcutaneous injectien in the pesterior aspect of the base of the tar at a dosage of 10 mg /b (6.6 mg /kg) bedy weight (SW) (1.5 ml per 100 lb BW. In beef and non-lactating dairy cattle, may aio be administered as a single subcutaneous injection in the middle third of the posterior aspect of the eat at a dosage of 3.0 mg CE/b (6.6 mg CE/kg) EW (1.5mml, sterile suspension per 100 lb EW).
Cattle (Acute Metritis):
Administer as a subcutaneous injection in the posterior aspect of the base of the earl to lactating dairy cattle at a dosage of 3.0 mg 1b (6.6 mg /kg) SW (1.5 ml per 100 is EW). Repeat this dose in the contra-lateral (opposite) ear approximately 72 hours following the initial dese.
Horses: Administer tee intrace cular injections to hones, 4 day apart, at a dose of 3.0 mg b (6.6 mg Ng). A maimom of 20ml per injecties site may be administered.
Dose: Cattle and Horses
CATTLE RESIDUE WARNINGS
Felleeing label use as either a single-dose or 2-dese regimen, a 13-day pre-slaughter withdrawal period is regulred after the last treatment.
Fellewing label ane as either a single-dese or 2-dese regimen, ne mill discard period is reguired for this product.
Use of dosages in excess of 3.0 mg ceftlefur egalvalents (CEVI (6.6 mg CE/ig) body weight or administration by unappraved routes (subcutaneous injection in the sedi or intramuscalar injection) may cause violative residues.
A withdrawal peried has nat been established for this product in pre-ruminating calves.
Do not use in calves to be processed for wal.
Warningr: Not for use in human, Keep this and all drogs out of reach of children. Do not use in horses intended for human consumption. To avid possible reactions, sers are advised to avoid direct contact of the product with the skin, eyes, mouth and ciething. Sensitization of the skin may be avoided by wearing protective gloves.
Cale Intra-arterial injection may occur during EXCEDE admintstrater which is likely to result in sadden death of the anima
Horses: Impediate onset of setzures or collagse in barses has been reported following EXCEDE saministration.
ANTIBACTERIAL WARNINGS:
Use ef antibactertal drigs in the atsence of a sesceptible bacterial Infection is unikety to provide benefit to treated animals and may increase the nak of the development of drug-restant bacter.

LARGE ANIMAL